Winsel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Winsel

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Frontiers in Oncology|June 1, 2012

Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell linesJulia Eschenbrenner, Sebastian Winsel, Stefanie Hammer, et al.

British Journal of Cancer|October 1, 2014

Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivoS Winsel, J Mäki-Jouppila, M Tambe, et al.

Cancer Research|July 3, 2008

Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopiloneJens Hoffmann, Ilio Vitale, Bernd Buchmann, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Frontiers in Oncology|June 1, 2012

Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell linesJulia Eschenbrenner, Sebastian Winsel, Stefanie Hammer, et al.

British Journal of Cancer|October 1, 2014

Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivoS Winsel, J Mäki-Jouppila, M Tambe, et al.

Cancer Research|July 3, 2008

Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopiloneJens Hoffmann, Ilio Vitale, Bernd Buchmann, et al.

Pageof 5